Clinical trials have shown that adults taking tirzepatide (brand-name) achieve significantly greater weight loss with an average reduction of about 20% of their body weight, compared to those taking semaglutide
Messages for older adults, people with underlying health conditions and their carers 22
Tirzepatide carries an FDA boxed warning for thyroid C-cell tumors plus warnings for pancreatitis, gallbladder disease, and hypoglycemia with insulin secretagogues
Belangrijk: BPC 157 is uitsluitend bedoeld voor onderzoeksgebruik en niet goedgekeurd voor menselijke consumptie
Goldstein et al., 2012 Found rapid decrease in swelling and immune-mediated tissue damage
Together, they promote angiogenesis (new blood vessel formation), which improves nutrient delivery and waste removal in damaged tissues, effectively shortening traditional healing timelines